Skip to content
Aerolink Canada

Zimbabwe Rejects ‘Lopsided’ American Healthcare Assistance Agreement Due to Data Fears

Medical aid illustration
The offered US funding was intended for initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on confidential biological samples.

This move was revealed after a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".

An official representative later clarified that the US was seeking genetic material for research and commercial purposes while was not willing to guarantee the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has appealed for more negotiations to secure a deal agreeable to all parties so the country's vital HIV programme can proceed.

Wider Background

This rejection follows a comparable situation in neighbouring Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the safety of citizens' medical information.

After resuming office recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

USAID had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and accountability.

According to statements, Sixteen African countries have to date agreed to these new health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," Tremont commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"The proposal required Zimbabwe to surrender its biological resources and data for a long time, with no corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.

"Put simply, our nation would supply the basic resources for scientific discovery without any assurance that the resulting innovations would be accessible to our population if a new disease outbreak arise."

National Interest and International Frameworks

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting structures previously set up via the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to deal with future pandemics.

"This system is intended to ensure that when a nation provides its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome ongoing dialogue with our American counterparts on how future co-operation could be arranged in a way that respects the sovereignty and dignity of both nations."

Health Experts Reaction

Medical experts stated it acknowledged the government's concerns, but suggested that talks need to persist since much of the country's HIV programmes were funded by external financing.

"In cases where technical issues exist, including those involving information security or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it said.

The halted deal highlights the ongoing tensions between accepting much-needed foreign assistance and protecting national sovereignty in an ever more data-driven world.

About the author

Hannah Moran

Aviation journalist and former pilot with over 15 years of experience covering aerospace technology and regulatory developments across North America.

Aerolink Canada

Type to search articles.